BioVie Inc. Appoints New CMO, Elects Directors
Ticker: BIVIW · Form: 8-K · Filed: Jul 30, 2024 · CIK: 1580149
| Field | Detail |
|---|---|
| Company | Biovie Inc. (BIVIW) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-election, personnel
Related Tickers: BIVI
TL;DR
BioVie just hired a new CMO and added two directors to the board.
AI Summary
BioVie Inc. announced on July 25, 2024, the appointment of Dr. Babak B. Moussavi as Chief Medical Officer and the election of Dr. Moussavi and Ms. Sarah E. Empey to its Board of Directors. The company also disclosed compensatory arrangements for its officers, though specific dollar amounts for these arrangements were not detailed in this filing.
Why It Matters
The appointment of a new Chief Medical Officer and board members signals potential strategic shifts or leadership changes within BioVie Inc. that could impact its drug development and business strategy.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can indicate internal shifts that may affect the company's future performance and strategic direction.
Key Players & Entities
- BioVie Inc. (company) — Registrant
- Dr. Babak B. Moussavi (person) — Appointed Chief Medical Officer and elected to Board of Directors
- Ms. Sarah E. Empey (person) — Elected to Board of Directors
- July 25, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer of BioVie Inc.?
Dr. Babak B. Moussavi has been appointed as the new Chief Medical Officer of BioVie Inc.
Who were elected to BioVie Inc.'s Board of Directors?
Dr. Babak B. Moussavi and Ms. Sarah E. Empey were elected to BioVie Inc.'s Board of Directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 25, 2024.
What is BioVie Inc.'s state of incorporation?
BioVie Inc. is incorporated in Nevada.
What is BioVie Inc.'s IRS Employer Identification Number?
BioVie Inc.'s IRS Employer Identification Number is 46-2510769.
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2024-07-30 17:15:30
Key Financial Figures
- $0.0001 — tered Class A Common Stock, Par Value $0.0001 Per Share BIVI The Nasdaq Stock Marke
Filing Documents
- bivi-20240725_8k.htm (8-K) — 22KB
- 0001520138-24-000251.txt ( ) — 189KB
- bivi-20240725.xsd (EX-101.SCH) — 3KB
- bivi-20240725_lab.xml (EX-101.LAB) — 33KB
- bivi-20240725_pre.xml (EX-101.PRE) — 22KB
- bivi-20240725_8k_htm.xml (XML) — 3KB
02 Departure of Directors or Certain Officers;
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On July 25, 2024, Steve Gorlin notified the Board of Directors (the "Board") of BioVie Inc. (the "Company") of his intention to resign as a director of the Company, effective immediately. Mr. Gorlin's resignation was not the result of any dispute or disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices. The Company expresses its gratitude to Mr. Gorlin for his service and contributions during his tenure on the Board. -1-
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BioVie INC. By: /s/ Joanne Wendy Kim Name: Joanne Wendy Kim Title: Chief Financial Officer Date: July 30, 2024 -2-